Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
  • Page of 1
Britt NS, Steed ME, Potter EM, Clough LA. Tigecycline for the Treatment of Severe and Severe Complicated Clostridium difficile Infection. Infect Dis Ther. 2014 Dec;3(2):321-31. doi: 10.1007/s40121-014-0050-x. Epub 2014 Dec 3. PubMed PMID: 25466443; PubMed Central PMCID: PMC4269622.
Britt NS, Potter EM, Patel N, Steed ME. Comparison of the Effectiveness and Safety of Linezolid and Daptomycin in Vancomycin-Resistant Enterococcal Bloodstream Infection: A National Cohort Study of Veterans Affairs Patients. Clin Infect Dis. 2015 Sep 15;61(6):871-8. doi: 10.1093/cid/civ444. Epub 2015 Jun 10. PubMed PMID: 26063715; PubMed Central PMCID: PMC4551009.
Britt NS, Patel N, Horvat RT, Steed ME. Vancomycin 24-Hour Area under the Curve/Minimum Bactericidal Concentration Ratio as a Novel Predictor of Mortality in Methicillin-Resistant Staphylococcus aureus Bacteremia. Antimicrob Agents Chemother. 2016 May;60(5):3070-5. doi: 10.1128/AAC.02714-15. Print 2016 May. PubMed PMID: 26953202; PubMed Central PMCID: PMC4862500.
Britt NS, Potter EM. Clinical epidemiology of vancomycin-resistant Enterococcus gallinarum and Enterococcus casseliflavus bloodstream infections. J Glob Antimicrob Resist. 2016 Jun;5:57-61. doi: 10.1016/j.jgar.2015.12.002. Epub 2015 Dec 21. PubMed PMID: 27274980; PubMed Central PMCID: PMC4889110.
Britt NS, Patel N, Shireman TI, El Atrouni WI, Horvat RT, Steed ME. Relationship between vancomycin tolerance and clinical outcomes in Staphylococcus aureus bacteraemia. J Antimicrob Chemother. 2017 Feb;72(2):535-542. doi: 10.1093/jac/dkw453. Epub 2016 Dec 20. PubMed PMID: 27999028; PubMed Central PMCID: PMC6075607.
Britt NS, Potter EM, Patel N, Steed ME. Comparative Effectiveness and Safety of Standard-, Medium-, and High-Dose Daptomycin Strategies for the Treatment of Vancomycin-Resistant Enterococcal Bacteremia Among Veterans Affairs Patients. Clin Infect Dis. 2017 Mar 1;64(5):605-613. doi: 10.1093/cid/ciw815. PubMed PMID: 28011602.
Britt NS, Potter EM, Patel N, Steed ME. Effect of Continuous and Sequential Therapy among Veterans Receiving Daptomycin or Linezolid for Vancomycin-Resistant Enterococcus faecium Bacteremia. Antimicrob Agents Chemother. 2017 May;61(5). doi: 10.1128/AAC.02216-16. Print 2017 May. PubMed PMID: 28264856; PubMed Central PMCID: PMC5404546.
Malek W, Yager J, Britt NS, More C, Hecox Z, Hoye-Simek A, Sullivan S, Faragon J, Patel N. Clinical outcomes associated with single tablet regimens: relationship between antiretroviral therapy pill burden and control of concomitant comorbidities among HIV-infected patients. J HIV Retrovirus. 2017 May; 3(1):1-7.
Britt NS, Potter EM, McKinnell JA, Patel N, Battersby SE, Steed ME. Secular Trends in Nosocomial Vancomycin-Resistant Enterococcal Bloodstream Infections Among United States Veterans Affairs Hospitals, Fiscal Years 2004 through 2014. Infect Control Hosp Epidemiol. 2017 Sep;38(9):1114-1116. doi: 10.1017/ice.2017.125. Epub 2017 Jul 11. PubMed PMID: 28693646.
Britt NS, Hagopian JC, Brennan DC, Pottebaum AA, Santos CAQ, Gharabagi A, Horwedel TA. Effects of recurrent urinary tract infections on graft and patient outcomes after kidney transplantation. Nephrol Dial Transplant. 2017 Oct 1;32(10):1758-1766. doi: 10.1093/ndt/gfx237. PubMed PMID: 28967964.
Britt NS, Potter EM, Patel N, Steed ME. Reply to Chanderraj et al. Clin Infect Dis. 2017 Oct 15;65(8):1427-1428. doi: 10.1093/cid/cix553. PubMed PMID: 29017243.
Britt NS, Tirmizi S, Ritchie DJ, Topal JE, McManus D, Nizet V, Casabar E, Sakoulas G. Telavancin for refractory MRSA bacteraemia in intermittent haemodialysis recipients. J Antimicrob Chemother. 2018 Mar 1;73(3):764-767. doi: 10.1093/jac/dkx437. PubMed PMID: 29244141; PubMed Central PMCID: PMC5890690.
Britt NS, Ritchie DJ, Kollef MH, Burnham CA, Durkin MJ, Hampton NB, Micek ST. Importance of Site of Infection and Antibiotic Selection in the Treatment of Carbapenem-Resistant Pseudomonas aeruginosa Sepsis. Antimicrob Agents Chemother. 2018 Apr;62(4). doi: 10.1128/AAC.02400-17. Print 2018 Apr. PubMed PMID: 29378722; PubMed Central PMCID: PMC5913923.
Britt NS, Ritchie DJ, Kollef MH, Burnham CD, Durkin MJ, Hampton NB, Micek ST. Clinical epidemiology of carbapenem-resistant gram-negative sepsis among hospitalized patients: Shifting burden of disease?. Am J Infect Control. 2018 Oct;46(10):1092-1096. doi: 10.1016/j.ajic.2018.03.013. Epub 2018 Apr 26. PubMed PMID: 29706365; PubMed Central PMCID: PMC6165681.
Roberts KL, Shuster JE, Britt NS, Balsara KR, Graetz TJ, Helwani M, Itoh A, Tellor BR. Evaluation of Clinical Outcomes with Phosphodiesterase-5 Inhibitor Therapy for Right Ventricular Dysfunction After Left Ventricular Assist Device Implantation. ASAIO J. 2019 Mar/Apr;65(3):264-269. doi: 10.1097/MAT.0000000000000809. PubMed PMID: 29750687.
Avery LM, Kuti JL, Weisser M, Egli A, Rybak MJ, Zasowski EJ, Arias CA, Contreras GA, Chong PP, Aitken SL, DiPippo AJ, Wang JT, Britt NS, Nicolau DP. Pharmacodynamic Analysis of Daptomycin-treated Enterococcal Bacteremia: It Is Time to Change the Breakpoint. Clin Infect Dis. 2019 May 2;68(10):1650-1657. doi: 10.1093/cid/ciy749. PubMed PMID: 30188976; PubMed Central PMCID: PMC6938208.
Ahmed A, Schriever C, Britt N, Yager J, Amin R, McGuey L, Patel N. Comparing drug interaction frequencies of various hepatitis C treatment regimens among monoinfected patients. Ann Hepatol. 2019 Jul - Aug;18(4):601-606. doi: 10.1016/j.aohep.2019.01.005. Epub 2019 May 4. PubMed PMID: 31078440.
Avery LM, Kuti JL, Weisser M, Egli A, Rybak MJ, Zasowski EJ, Arias CA, Contreras GA, Chong PP, Aitken SL, DiPippo AJ, Wang JT, Britt NS, Nicolau DP. Reply to Cheng and Chuang. Clin Infect Dis. 2019 Aug 16;69(5):903-904. doi: 10.1093/cid/ciz081. PubMed PMID: 30715199.
Avery LM, Kuti JL, Weisser M, Egli A, Rybak MJ, Zasowski EJ, Arias CA, Contreras GA, Chong PP, Aitken SL, DiPippo AJ, Wang JT, Britt NS, Nicolau DP. Pharmacodynamics of daptomycin in combination with other antibiotics for the treatment of enterococcal bacteraemia. Int J Antimicrob Agents. 2019 Sep;54(3):346-350. doi: 10.1016/j.ijantimicag.2019.07.002. Epub 2019 Jul 5. PubMed PMID: 31284042.
Britt NS, Hazlett DS, Horvat RT, Liesman RM, Steed ME. Activity of pulmonary vancomycin exposures versus planktonic and biofilm isolates of methicillin-resistant Staphylococcus aureus from cystic fibrosis sputum. Int J Antimicrob Agents. 2020 Apr;55(4):105898. doi: 10.1016/j.ijantimicag.2020.105898. Epub 2020 Jan 11. PubMed PMID: 31931147; PubMed Central PMCID: PMC7186148.
Mohan A, Agarwal S, Clauss M, Britt NS, Dhillon NK. Extracellular vesicles: novel communicators in lung diseases. Respir Res. 2020 Jul 8;21(1):175. doi: 10.1186/s12931-020-01423-y. Review. PubMed PMID: 32641036; PubMed Central PMCID: PMC7341477.
Badowski ME, Britt N, Huesgen EC, Lewis MM, Miller MM, Nowak K, Sherman E, Smith RO. Pharmacotherapy considerations in transgender individuals living with human immunodeficiency virus. Pharmacotherapy. 2021 Mar;41(3):299-314. doi: 10.1002/phar.2499. Epub 2021 Feb 27. Review. PubMed PMID: 33404067; PubMed Central PMCID: PMC8128446.
What would you like to do?
  • Page of 1